Private Equity Reporting Group Guidelines
Enhanced Disclosure related to the Guidelines
Vitruvian Partners LLP (“Vitruvian”) is a member of UK Private Capital (formerly BVCA) and as such commits to provide data to UK Private Capital to enable it to conduct enhanced research into the private equity industry. Vitruvian is pleased to conform on a “comply or explain” basis with the Guidelines. Vitruvian also seeks to promote conformity with the Guidelines, where relevant, on the part of any portfolio companies which fall within the scope of the Guidelines.
Leadership and History of Vitruvian
Founded in 2006, Vitruvian specialises in making control-centric investments in higher growth, middle-market companies, predominantly across the EMEA region. Vitruvian is principally based in London, but with offices in Luxembourg, Madrid, Miami, Mumbai, Munich, San Francisco, Shanghai, Singapore and Stockholm. Vitruvian is controlled and owned by its partners, promoting strong alignment of interest with its Limited Partners and investment outcomes. Vitruvian focuses on Dynamic Situations, for which it has raised five funds to date, characterised by high growth and change across asset-light industries. Vitruvian Funds have backed over 100 companies and have assets under management of c.€20 billion. Vitruvian is a member of UK Private Capital and a signatory of the Principles for Responsible Investment (“PRI”). Please refer to the About Us section of the Vitruvian website for further information.
Structure of Vitruvian
Vitruvian is authorised and regulated in the United Kingdom by the Financial Conduct Authority as an Alternative Investment Fund Manager (AIFM). Vitruvian currently manages the following private equity funds: Vitruvian Investment Partnership II (“VIP II”), Vitruvian Investment Partnership III (“VIP III”), Vitruvian Investment Partnership I CF (“VIP I CF”), Vitruvian Investment Partnership IV (“VIP IV”) and Vitruvian Investment Partnership V (“VIP V”) (together, the “Vitruvian Funds”). The Vitruvian Funds are closed-ended with a typical fixed term life of ten years (subject to extension). Investments are typically made during the first five years of a Vitruvian Fund’s life, held for a number of years and divested prior to the end of the fixed term.
Vitruvian’s Investor Base
The charts below provide an overview of the composition of the overall investor base across the Vitruvian Funds (excluding commitments by the general partners and other Vitruvian affiliates).
Note: As of February 2026
Investments in UK-based companies
The following UK portfolio companies held by Vitruvian Funds currently fall within scope under the Guidelines:
- Sykes Cottages
Conflicts of Interest
Vitruvian maintains detailed written policies and procedures as part of its operational control framework. These include a Conflicts of Interest Policy, which sets out Vitruvian’s process for identifying and managing actual and potential conflicts of interest which may arise in respect of both Vitruvian and the Vitruvian Funds. All of Vitruvian’s Compliance policies and procedures, which seek to address the regulatory obligations to which Vitruvian is subject, are monitored by Vitruvian’s Chief Compliance Officer and the relevant Vitruvian internal committees. Any actual or potential conflict which may arise between Vitruvian and a Vitruvian Fund (or between different Vitruvian Funds), are managed in accordance with Vitruvian’s legal and regulatory obligations and the relevant Fund’s (or Funds’) constitutional documents.